These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39421533)

  • 21. Comparison of Three Methods of Tonometry in Patients with Inactive Thyroid-Associated Orbitopathy.
    Karhanová M; Kalitová J; Malušková M; Schovánek J; Zapletalová J; Mlčák P; Marešová K
    Cesk Slov Oftalmol; 2023; 79(6):318-323. PubMed ID: 38086704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
    Wu T; Tang DR; Wang F; Xia S; Sun FY
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
    Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
    Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association.
    Chatzistefanou KI; Samara C; Asproudis I; Brouzas D; Moschos MM; Tsianta E; Piaditis G
    Clin Interv Aging; 2017; 12():359-366. PubMed ID: 28243072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy.
    Huang X; Tang W; Shen Y; He L; Tong F; Liu S; Li J; Li P; Zhang Y; Ma X; Wei R; Yang W
    Biomed Eng Online; 2023 Feb; 22(1):7. PubMed ID: 36739403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid eye disease: a Southeast Asian experience.
    Lim NC; Sundar G; Amrith S; Lee KO
    Br J Ophthalmol; 2015 Apr; 99(4):512-8. PubMed ID: 25361748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy.
    Park SW; Kim N; Choung HK; Khwarg SI
    Korean J Ophthalmol; 2012 Oct; 26(5):319-23. PubMed ID: 23060717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peribulbar injection of glucocorticoids for thyroid-associated ophthalmopathy and factors affecting therapeutic effectiveness: A retrospective cohort study of 386 cases.
    Wang Y; Du B; Yang M; Zhu Y; He W
    Exp Ther Med; 2020 Sep; 20(3):2031-2038. PubMed ID: 32782513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eye muscle force development in thyroid-associated ophthalmopathy in different stages of disease.
    Tian S; Bolzani R; Benassi M; Lennerstrand G
    Acta Ophthalmol Scand; 2007 Jun; 85(4):431-7. PubMed ID: 17559468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab for thyroid-associated ophthalmopathy.
    Kang S; Hamed Azzam S; Minakaran N; Ezra DG
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009226. PubMed ID: 35709102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy.
    Ye Y; Hu F; Ji Y; Wang R; Zhu K; Kong Q
    BMC Ophthalmol; 2023 May; 23(1):217. PubMed ID: 37193956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of thyroid associated ophthalmopathy with myasthenia Graves in 12 patients].
    Ji H; Yang J; Zhu H; Jiang W; Sun F
    Zhonghua Yan Ke Za Zhi; 2015 Aug; 51(8):581-5. PubMed ID: 26696574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy.
    He J; Wu Z; Yan J; Yang H; Mao Y; Ai S; Chen Z
    Yan Ke Xue Bao; 2004 Mar; 20(1):10-4. PubMed ID: 15124526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the relationship between levator palpebrae superioris and thyroid-associated ophthalmopathy using the Dixon-T2WI sequence.
    Liu D; Duan Y; Huang K; Song C; Ouyang Y; Lin X; Shen J; Chen H
    Front Endocrinol (Lausanne); 2024; 15():1387217. PubMed ID: 38868741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
    Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
    JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary Study on the Correlation Between Episcleral Venous Pressure and Intraocular Pressure in TAO Patients and Its Clinical Value.
    Fan X; Zha X; Wang N; Han Y
    Altern Ther Health Med; 2024 Oct; 30(10):522-527. PubMed ID: 38401100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.
    Reddy SV; Jain A; Yadav SB; Sharma K; Bhatia E
    Indian J Med Res; 2014 Jan; 139(1):99-104. PubMed ID: 24604044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modified orbital decompression for severe thyroid associated ophthalmopathy].
    Wang Y; Xiao LH; Yang ZK; Li YY
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):242-9. PubMed ID: 23866706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of 339 cases of thyroid-associated ophthalmopathy].
    He JF; Wu ZY; Yang HS; Yan JH; Mao YX; Chen ZC; Ai SM
    Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):368-72. PubMed ID: 15312599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.